20 free expert talks and eBooks to help you heal SIBO, acid reflux, GERD, microbiome imbalances and more.
We’ve collected our top expert talks and eBooks to create this incredible, self-learning gut health bundle… for FREE!
Education about gut and microbiome health has never been as prevalent as it is now — in fact, it can be pretty overwhelming. Our gut health bundle will help you more easily explore dietary protocols, top supplements and probiotics, and the latest research on how genetics impact your biome.
We know it can be a struggle to find the time to learn from so many great health resources out there. Fortunately, these expert talks and eBooks are yours INDEFINITELY. Meaning, you’ll have access to learn from them at your own pace!
Learn incredible wisdom and insights from such well-known gut health experts as:
Dr. Partha Nandi
Shivan Sarna
Misty Williams
Donna Gates
Sayer Ji
Dr. Sarah Ballantyne
And more!
You’ll gain immediate access to the expert talks and eBooks, and retain access to them indefinitely — you can learn and make changes to your life at your own pace.
There’s no catch. No purchase required. No commitment necessary.
BONUS EBOOKS & GIFTS
Gut Recovery Recipes from Donna Gates
Low Sugar Desserts Cookbook from Partha Nandi
Healing Rosie’s Optimal Lab Tracker from Misty Williams
SIBO SOS® Cookbook from Shivan Sarna
Gut Health and Cannabidiol eBook from Rooted Apothecary
GreenMedInfo’s Science of Longevity eReport from Sayer Ji
Newly prescribed ADHD medications may cause psychosis, study finds
“Those those who have taken the drug and tolerated it well, should not be concerned,” experts say.
By Linda Carroll
Certain medications used to treat ADHD in teens and young adults may be more likely to cause symptoms such as paranoia, hallucinations, delusions and hearing voices, a new study suggests.
Researchers found that patients who had been newly prescribed amphetamines, such as Adderall and Vyvanse, were more likely to develop psychosis than those who had received a prescription for methylphenidates, such as Ritalin and Concerta, according to the study published Wednesday by the New England Journal of Medicine.
While psychosis with either class of medication is still relatively rare — occurring at a rate of one in 660 patients — experts cautioned that patients should know about the increased risk.
They also noted that the increased risk was only for those who recently began treatment with a new amphetamine prescription for ADHD and that those who have taken the drug and tolerated it well should not be concerned.
“If someone has been on Adderall, they’re tolerating it well, it’s helpful for their symptoms, and they’re taking it as prescribed, there’s really not much cause for concern,” said the study’s lead author, Dr. Lauren Moran, an assistant professor at the Harvard Medical School and a psychiatrist at McLean Hospital.
“Still you have to think about it from the public health scale,” Moran added. “If it’s a fraction of a percent of millions of people then that means there could be thousands of additional cases of psychosis across the United States. In my mind that’s a serious problem.”
Amphetamine prescriptions to treat ADHD have been steadily rising, increasing cause for concern.
“At the beginning of our study, in 2005, a patient had about a 50-50 chance of getting Adderall or Ritalin. There has been a huge increase in Adderall prescriptions over the course of the study to almost four times as many prescriptions for Adderall,” Moran said.
As the number of students with psychosis grew, Moran decided to look further into the issue. What she found was that a common factor among the cases seemed to be amphetamine prescriptions for ADHD.
To determine whether there really was a higher risk of psychosis associated with amphetamines, Moran and her colleagues turned to two large commercial insurance claims databases, which included more than 5 million patients with a stimulant prescription.
The researchers focused on patients 13 to 25 years old who started taking either amphetamines or methylphenidates from Jan. 1, 2004, to Sept. 30, 2015. Among more than 221,846 patients included in the study, 110,923 were taking methylphenidate and 110,923 were taking amphetamines. The study focused only on new users of the medication.
New cases of psychosis were identified in 106 of the patients taking methylphenidate, as compared to 237 in those taking amphetamines, nearly double the rate.
The Food and Drug Administration has been aware of the issue of psychosis. In fact, in 2007 the federal agency mandated that ADHD medication labels include warnings about potential psychiatric and heart issues.
In Moran’s experience, ADHD patients hospitalized for psychosis recovered in two weeks on average, but some patients took as long as two months.
Moran isn’t suggesting that ADHD medications are too dangerous to be prescribed, but wants to inform patients about its use.
“We’re trying to raise awareness,” she said. “Physicians need to be aware of this when prescribing, and people who are getting these medications from friends in college need to know this is a risk.”
Experts interviewed by NBC News agreed that there should be greater awareness of the risks associated with these medications.
The new study emphasizes the need for physicians to be “extremely careful to diagnose ADHD appropriately and to provide appropriate treatment,” said Dr. Antoine Douaihy, a professor of psychiatry and medicine at the University of Pittsburgh School of Medicine and senior academic director of Addiction Medicine Services at the University of Pittsburgh Medical Center. “And they need to monitor patients closely so they can identify early signs of behavioral changes related to psychotic or manic symptoms.”
While the study shows that psychosis is a risk for both stimulants, it does suggest that amphetamines “may be more implicated than methylphenidates,” said Dr. David Goodman, an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and director of the Adult Attention Deficit Disorder Center of Maryland. A limitation of the study is that the databases used by the researchers don’t have detailed information on how patients were diagnosed, Goodman said.
Goodman hopes that the study, and the coverage it gets, will make doctors and patients treat these medications with care. But he hopes all the attention won’t scare patients away from ADHD drugs.
“Left untreated, ADHD has so many negative consequences,” Goodman said.
Linda Carroll is a regular health contributor to NBC News and Reuters Health. She is coauthor of “The Concussion Crisis: Anatomy of a Silent Epidemic” and “Out of the Clouds: The Unlikely Horseman and the Unwanted Colt Who Conquered the Sport of Kings.”
Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013–2018
Neema Mafi, Hayley D. Yaglom, Craig Levy, Anissa Taylor, Catherine O’Grady, Heather Venkat, Kenneth K. Komatsu, Brentin Roller, Maria T. Seville, Shimon Kusne, John Leander Po, Shannon Thorn, and Neil M. Ampel
Abstract
Tick-borne relapsing fever (TBRF) is a bacterial infection transmitted by tick bites that occurs in several different parts of the world, including the western United States. We describe 6 cases of TBRF acquired in the White Mountains of Arizona, USA, and diagnosed during 2013–2018. All but 1 case-patient had recurrent fever, and some had marked laboratory abnormalities, including leukopenia, thrombocytopenia, hyperbilirubinemia, and elevated aminotransaminases. One patient had uveitis.Diagnosis was delayed in 5 of the cases; all case-patients responded to therapy with doxycycline. Two patients had Jarisch-Herxheimer reactions. The White Mountains of Arizona have not been previously considered a region of high incidence for TBRF. These 6 cases likely represent a larger number of cases that might have been undiagnosed. Clinicians should be aware of TBRF in patients who reside, recreate, or travel to this area and especially for those who sleep overnight in cabins there.
_______________
**Comment**
Do you see the trend yet? Ticks, pathogens, and disease where they aren’t supposed to exist. Yet they do. This study also demonstrates that the Lyme caused by B. burgdorferi is NOT the only borrelia spirochete we need to be concerned about. While the study states,
“In the United States, B. hermsii is thought to be the most common cause of TBRF, and transmission is associated with the bite of soft O. hermsi ticks. Ornithodoros spp,”
they are not the sole perps as seen below. A U.S. solider acquired TBRF with the B. turicataestrain and in Europe the strain was caused by B. corocidurae. The truly frightening aspect is the potential rapid transmission.
Once infected, they remain infected for the rest of their lives, which can be up to ten years.
Attachment is painless
They are rapid night feeders (5-60min)
Due to their rapid feeding they are rarely found or leave lesions
Patient in study suffered with headache, nausea, & pain behind knees
Had numerous lesions which resolved after 6 days (without treatment)
Developed persistent fever
Developed thrombocytopenia (low platelets)
Developed elevated Erythrocyte sedimentation rate & C-reactive protein
Improved rapidly with doxycycline
Platelet count normalized within 2 weeks
Asymptomatic soldiers with similar exposure were treated prophylactically
TBRF is a neglected and probably underdiagnosed disease
Published cases in Texas have been supported by serology for the TBRF group, exposure location, and tick collections, but the authors state successful identification of B. turicatae in a human has not been reported
Vibrant Presents Dr Jill Carnahan for Mold and Mycotoxins
Join us for this highly educational session with Dr Jill Carnahan, a leading expert in mold and mycotoxin illnesses while she discusses the available technology and testing methods for mold and mycotoxin exposure, walks through some case studies, and gives suggestions for pre-test measures and treatment.
Time: Mar 26, 2019 6:00 PM in Central Time (US and Canada)
Todd Condon didn’t get a diagnosis of Lyme until it was too late.
TICONDEROGA | Todd Condon creates art on his iPad, not necessarily because he prefers to, but because the joints in his fingers have seized up to the point that he cannot grip brushes and pens. He still has good days, which to him means getting to the grocery store and back without incident, or being relatively free of painful flare-ups that leave him virtually immobile.
All because of a tick no bigger than a celery seed.
Condon contracted Lyme disease three years ago, and the illness has become chronic largely, he says, because of a lengthy delay in its diagnosis. Doctors wrote off his condition to joint maladies or fibromyalgia and balked at his repeated requests for advanced blood work.
His joints and head throbbed, he was tired all the time, and he lost coordination and was easily confused.
“Everybody who knew me said, ‘What’s wrong with this guy?’” Condon said. “The scary thing was, I didn’t know myself.”
‘WHAT DO YOU DO NOW?’
For 25 years, Condon, of Eagle Lake, had worked for International Paper in Ticonderoga, but the disease eventually overcame his ability to do the job he loved. By this time he knew what was dogging him, having finally been availed of a specialist who performed the blood work Condon had wanted two years before.
The results were sobering. Not only did he have Lyme, he tested positive as well for West Nile disease and Bartonella, co-infections likely spread by the same tick.
Had Condon gotten the blood tests when he wanted, things might have been different. But now the condition had worked its way into his nervous system and advanced to the point that treatment was far less effective.
Physicians poured on the antibiotics, six months’ worth of pills taken twice daily and, when that didn’t work, prescribed a half-hour a day’s worth of intravenous drugs for a month. That didn’t work either.
“If the antibiotic isn’t doing anything, what do you do now?” he said.
RAISING AWARENESS
Condon says he still has hope, if not relief. His other goal is to raise awareness of Lyme and help people who are in chronic pain, no matter what the cause. To that end he has started a Chronic Pain and Illness Support Group that meets at the Ticonderoga Hospital on the second Sunday of every month at 7 p.m.
“All are welcome to attend,” he said. “It’s a place where people can share their stories and feel they have a caring and supportive environment.”
Meanwhile, he sifts through medical and social-media sites hoping to find evidence of a cure.
SEVERE SPIKE
Lyme was relatively unknown in the Adirondacks, until climate change expanded the range of the deer tick that carries it. According to research by Lee Ann Sporn, a professor at Paul Smith’s College, Essex County saw a severe spike in Lyme disease beginning in 2012.
But scientists and physicians have been dismayed this year that the New York Senate has to date failed to provide for a continuance of the funding that has paid for baseline research — an indication that Lyme is still not garnering the attention it should.
In a statement sent to the Senate in support of funding, Dr. Russ Hartung, emergency physician at Champlain Valley Physicians Hospital in Plattsburgh, said research into tick populations and infection rates provide critical guidance to the medical community.
He also said the seriousness of the illness is still understated.
“The general public may not realize that Lyme causes more than just achy joints and a rash,” he wrote. “It can cause critical illness like cardiac disease and meningitis, and the other tick-borne pathogens can be even worse.”
According to Spron’s research, “it’s a coin flip” as to whether a tick is a carrier or not, so it’s best to assume that any tick bite is cause for concern. Checking for ticks after being out in the bush is critical, since if the tick is pulled off within 24 hours, the disease, studies indicate, probably has not had time to be transmitted. Tick bites are also more dangerous in July and August than in the spring and fall.
WALKING EXHIBIT
Condon believes Lyme is still going undiagnosed and that too many in the medical and insurance industries still treat it as a phantom disease. It can be hard to find doctors that have a good, up-to-date understanding of Lyme, he said.
“I don’t think it’s gotten the proper attention,” he said. “If you don’t catch it quickly, you can get in trouble.”
Lyme is also insidious because it can come with co-infections and can show up differently in different people. Someone might be infected, but show no symptoms. And when they do show, those symptoms can vary radically, making diagnosis more difficult.
“You have to be your own advocate,” Condon said. “Find a doctor who is Lyme literate.”
Patients need to be careful too that the physician’s care will be covered by insurance, since companies sometimes balk at paying for Lyme treatments.
Condon said he’s a walking exhibit of the need for early treatment.
“It’s been three years of hell,” he said. “It feels like my joints are being torn apart on the inside. Things that people take for granted become a struggle. I just hope the word spreads far enough that people know what to do, and that no one else gets to this point.”
“The authorities have been using tick expansion and climate change to get research dollars. Climate change is a popular topic right now, and that is a great source of funding for related research. However, any research on ticks and climate change is inconclusive––in essence, there is no validity. The long-range, futuristic projections and statistical models are bogus science because blacklegged ticks have already been found in northern Canada. In fact, we documented blacklegged ticks on migratory songbirds in northern Alberta dating back to 1998. Any allocation of government funding for ticks and climate change research is a complete waste of taxpayers’ money. It will not help Lyme disease patients one iota.” Independent Canadian tick researcher, John Scott